 | • レポートコード：MRC2312MG13100 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の化学CDMO市場規模と予測を収録しています。・世界の化学CDMO市場：売上、2018年-2023年、2024年-2029年 ・世界の化学CDMO市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の化学CDMO市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「低分子製剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 化学CDMOのグローバル主要企業は、Lonza、 Catalent、 GenScript Biotech、 Biosynth、 Otsuka Chemical、 AGC Pharma Chemicals、 Jubilant Bhartia Group、 Sinopep Allsino Bio Pharmaceutical、 Wuxi Biologics (Cayman)、 Porton Fine Chemicals、 Zhejiang Jiuzhou Pharmaceutical、 NYCRIST、 Guangzhou Bositao Controlled Release Pharmaceutical、 Charles River、 Cambrex、 Almac Group、 Jubilant Pharmova、 Cambrex、 Siegfried Holding AG、 Aenova Group、 Samsung BioLogicsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、化学CDMOのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の化学CDMO市場：タイプ別、2018年-2023年、2024年-2029年 世界の化学CDMO市場：タイプ別市場シェア、2022年 ・低分子製剤、高分子製剤 世界の化学CDMO市場：用途別、2018年-2023年、2024年-2029年 世界の化学CDMO市場：用途別市場シェア、2022年 ・製薬会社、バイオテクノロジー会社、その他 世界の化学CDMO市場：地域・国別、2018年-2023年、2024年-2029年 世界の化学CDMO市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における化学CDMOのグローバル売上、2018年-2023年 ・主要企業における化学CDMOのグローバル売上シェア、2022年 ・主要企業における化学CDMOのグローバル販売量、2018年-2023年 ・主要企業における化学CDMOのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Lonza、 Catalent、 GenScript Biotech、 Biosynth、 Otsuka Chemical、 AGC Pharma Chemicals、 Jubilant Bhartia Group、 Sinopep Allsino Bio Pharmaceutical、 Wuxi Biologics (Cayman)、 Porton Fine Chemicals、 Zhejiang Jiuzhou Pharmaceutical、 NYCRIST、 Guangzhou Bositao Controlled Release Pharmaceutical、 Charles River、 Cambrex、 Almac Group、 Jubilant Pharmova、 Cambrex、 Siegfried Holding AG、 Aenova Group、 Samsung BioLogics ************************************************************* ・調査・分析レポートの概要 化学CDMO市場の定義 市場セグメント 世界の化学CDMO市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の化学CDMO市場規模 世界の化学CDMO市場規模：2022年 VS 2029年 世界の化学CDMO市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの化学CDMOの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の化学CDMO製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：低分子製剤、高分子製剤 化学CDMOのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：製薬会社、バイオテクノロジー会社、その他 化学CDMOの用途別グローバル売上・予測 ・地域別市場分析 地域別化学CDMO市場規模 2022年と2029年 地域別化学CDMO売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Lonza、 Catalent、 GenScript Biotech、 Biosynth、 Otsuka Chemical、 AGC Pharma Chemicals、 Jubilant Bhartia Group、 Sinopep Allsino Bio Pharmaceutical、 Wuxi Biologics (Cayman)、 Porton Fine Chemicals、 Zhejiang Jiuzhou Pharmaceutical、 NYCRIST、 Guangzhou Bositao Controlled Release Pharmaceutical、 Charles River、 Cambrex、 Almac Group、 Jubilant Pharmova、 Cambrex、 Siegfried Holding AG、 Aenova Group、 Samsung BioLogics ... |
This research report provides a comprehensive analysis of the Chemical CDMO market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Chemical CDMO market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Chemical CDMO, challenges faced by the industry, and potential opportunities for market players.
The global Chemical CDMO market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Chemical CDMO market presents opportunities for various stakeholders, including Pharmaceutical Company, Biotechnology Company. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Chemical CDMO market. Additionally, the growing consumer demand present avenues for market expansion.
The global Chemical CDMO market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Chemical CDMO market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Chemical CDMO market.
Market Overview: The report provides a comprehensive overview of the Chemical CDMO market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Small Molecule Preparations, Macromolecule Preparations), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Chemical CDMO market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Chemical CDMO market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Chemical CDMO market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Chemical CDMO market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Chemical CDMO market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Chemical CDMO market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Chemical CDMO, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Chemical CDMO market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Chemical CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Small Molecule Preparations
Macromolecule Preparations
Market segment by Application
Pharmaceutical Company
Biotechnology Company
Others
Global Chemical CDMO Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Lonza
Catalent
GenScript Biotech
Biosynth
Otsuka Chemical
AGC Pharma Chemicals
Jubilant Bhartia Group
Sinopep Allsino Bio Pharmaceutical
Wuxi Biologics (Cayman)
Porton Fine Chemicals
Zhejiang Jiuzhou Pharmaceutical
NYCRIST
Guangzhou Bositao Controlled Release Pharmaceutical
Charles River
Cambrex
Almac Group
Jubilant Pharmova
Cambrex
Siegfried Holding AG
Aenova Group
Samsung BioLogics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chemical CDMO, market overview.
Chapter 2: Global Chemical CDMO market size in revenue.
Chapter 3: Detailed analysis of Chemical CDMO company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chemical CDMO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Chemical CDMO Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chemical CDMO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chemical CDMO Overall Market Size
2.1 Global Chemical CDMO Market Size: 2022 VS 2029
2.2 Global Chemical CDMO Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chemical CDMO Players in Global Market
3.2 Top Global Chemical CDMO Companies Ranked by Revenue
3.3 Global Chemical CDMO Revenue by Companies
3.4 Top 3 and Top 5 Chemical CDMO Companies in Global Market, by Revenue in 2022
3.5 Global Companies Chemical CDMO Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chemical CDMO Players in Global Market
3.6.1 List of Global Tier 1 Chemical CDMO Companies
3.6.2 List of Global Tier 2 and Tier 3 Chemical CDMO Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Chemical CDMO Market Size Markets, 2022 & 2029
4.1.2 Small Molecule Preparations
4.1.3 Macromolecule Preparations
4.2 By Type – Global Chemical CDMO Revenue & Forecasts
4.2.1 By Type – Global Chemical CDMO Revenue, 2018-2023
4.2.2 By Type – Global Chemical CDMO Revenue, 2024-2029
4.2.3 By Type – Global Chemical CDMO Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Chemical CDMO Market Size, 2022 & 2029
5.1.2 Pharmaceutical Company
5.1.3 Biotechnology Company
5.1.4 Others
5.2 By Application – Global Chemical CDMO Revenue & Forecasts
5.2.1 By Application – Global Chemical CDMO Revenue, 2018-2023
5.2.2 By Application – Global Chemical CDMO Revenue, 2024-2029
5.2.3 By Application – Global Chemical CDMO Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Chemical CDMO Market Size, 2022 & 2029
6.2 By Region – Global Chemical CDMO Revenue & Forecasts
6.2.1 By Region – Global Chemical CDMO Revenue, 2018-2023
6.2.2 By Region – Global Chemical CDMO Revenue, 2024-2029
6.2.3 By Region – Global Chemical CDMO Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Chemical CDMO Revenue, 2018-2029
6.3.2 US Chemical CDMO Market Size, 2018-2029
6.3.3 Canada Chemical CDMO Market Size, 2018-2029
6.3.4 Mexico Chemical CDMO Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Chemical CDMO Revenue, 2018-2029
6.4.2 Germany Chemical CDMO Market Size, 2018-2029
6.4.3 France Chemical CDMO Market Size, 2018-2029
6.4.4 U.K. Chemical CDMO Market Size, 2018-2029
6.4.5 Italy Chemical CDMO Market Size, 2018-2029
6.4.6 Russia Chemical CDMO Market Size, 2018-2029
6.4.7 Nordic Countries Chemical CDMO Market Size, 2018-2029
6.4.8 Benelux Chemical CDMO Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Chemical CDMO Revenue, 2018-2029
6.5.2 China Chemical CDMO Market Size, 2018-2029
6.5.3 Japan Chemical CDMO Market Size, 2018-2029
6.5.4 South Korea Chemical CDMO Market Size, 2018-2029
6.5.5 Southeast Asia Chemical CDMO Market Size, 2018-2029
6.5.6 India Chemical CDMO Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Chemical CDMO Revenue, 2018-2029
6.6.2 Brazil Chemical CDMO Market Size, 2018-2029
6.6.3 Argentina Chemical CDMO Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Chemical CDMO Revenue, 2018-2029
6.7.2 Turkey Chemical CDMO Market Size, 2018-2029
6.7.3 Israel Chemical CDMO Market Size, 2018-2029
6.7.4 Saudi Arabia Chemical CDMO Market Size, 2018-2029
6.7.5 UAE Chemical CDMO Market Size, 2018-2029
7 Chemical CDMO Companies Profiles
7.1 Lonza
7.1.1 Lonza Company Summary
7.1.2 Lonza Business Overview
7.1.3 Lonza Chemical CDMO Major Product Offerings
7.1.4 Lonza Chemical CDMO Revenue in Global Market (2018-2023)
7.1.5 Lonza Key News & Latest Developments
7.2 Catalent
7.2.1 Catalent Company Summary
7.2.2 Catalent Business Overview
7.2.3 Catalent Chemical CDMO Major Product Offerings
7.2.4 Catalent Chemical CDMO Revenue in Global Market (2018-2023)
7.2.5 Catalent Key News & Latest Developments
7.3 GenScript Biotech
7.3.1 GenScript Biotech Company Summary
7.3.2 GenScript Biotech Business Overview
7.3.3 GenScript Biotech Chemical CDMO Major Product Offerings
7.3.4 GenScript Biotech Chemical CDMO Revenue in Global Market (2018-2023)
7.3.5 GenScript Biotech Key News & Latest Developments
7.4 Biosynth
7.4.1 Biosynth Company Summary
7.4.2 Biosynth Business Overview
7.4.3 Biosynth Chemical CDMO Major Product Offerings
7.4.4 Biosynth Chemical CDMO Revenue in Global Market (2018-2023)
7.4.5 Biosynth Key News & Latest Developments
7.5 Otsuka Chemical
7.5.1 Otsuka Chemical Company Summary
7.5.2 Otsuka Chemical Business Overview
7.5.3 Otsuka Chemical Chemical CDMO Major Product Offerings
7.5.4 Otsuka Chemical Chemical CDMO Revenue in Global Market (2018-2023)
7.5.5 Otsuka Chemical Key News & Latest Developments
7.6 AGC Pharma Chemicals
7.6.1 AGC Pharma Chemicals Company Summary
7.6.2 AGC Pharma Chemicals Business Overview
7.6.3 AGC Pharma Chemicals Chemical CDMO Major Product Offerings
7.6.4 AGC Pharma Chemicals Chemical CDMO Revenue in Global Market (2018-2023)
7.6.5 AGC Pharma Chemicals Key News & Latest Developments
7.7 Jubilant Bhartia Group
7.7.1 Jubilant Bhartia Group Company Summary
7.7.2 Jubilant Bhartia Group Business Overview
7.7.3 Jubilant Bhartia Group Chemical CDMO Major Product Offerings
7.7.4 Jubilant Bhartia Group Chemical CDMO Revenue in Global Market (2018-2023)
7.7.5 Jubilant Bhartia Group Key News & Latest Developments
7.8 Sinopep Allsino Bio Pharmaceutical
7.8.1 Sinopep Allsino Bio Pharmaceutical Company Summary
7.8.2 Sinopep Allsino Bio Pharmaceutical Business Overview
7.8.3 Sinopep Allsino Bio Pharmaceutical Chemical CDMO Major Product Offerings
7.8.4 Sinopep Allsino Bio Pharmaceutical Chemical CDMO Revenue in Global Market (2018-2023)
7.8.5 Sinopep Allsino Bio Pharmaceutical Key News & Latest Developments
7.9 Wuxi Biologics (Cayman)
7.9.1 Wuxi Biologics (Cayman) Company Summary
7.9.2 Wuxi Biologics (Cayman) Business Overview
7.9.3 Wuxi Biologics (Cayman) Chemical CDMO Major Product Offerings
7.9.4 Wuxi Biologics (Cayman) Chemical CDMO Revenue in Global Market (2018-2023)
7.9.5 Wuxi Biologics (Cayman) Key News & Latest Developments
7.10 Porton Fine Chemicals
7.10.1 Porton Fine Chemicals Company Summary
7.10.2 Porton Fine Chemicals Business Overview
7.10.3 Porton Fine Chemicals Chemical CDMO Major Product Offerings
7.10.4 Porton Fine Chemicals Chemical CDMO Revenue in Global Market (2018-2023)
7.10.5 Porton Fine Chemicals Key News & Latest Developments
7.11 Zhejiang Jiuzhou Pharmaceutical
7.11.1 Zhejiang Jiuzhou Pharmaceutical Company Summary
7.11.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
7.11.3 Zhejiang Jiuzhou Pharmaceutical Chemical CDMO Major Product Offerings
7.11.4 Zhejiang Jiuzhou Pharmaceutical Chemical CDMO Revenue in Global Market (2018-2023)
7.11.5 Zhejiang Jiuzhou Pharmaceutical Key News & Latest Developments
7.12 NYCRIST
7.12.1 NYCRIST Company Summary
7.12.2 NYCRIST Business Overview
7.12.3 NYCRIST Chemical CDMO Major Product Offerings
7.12.4 NYCRIST Chemical CDMO Revenue in Global Market (2018-2023)
7.12.5 NYCRIST Key News & Latest Developments
7.13 Guangzhou Bositao Controlled Release Pharmaceutical
7.13.1 Guangzhou Bositao Controlled Release Pharmaceutical Company Summary
7.13.2 Guangzhou Bositao Controlled Release Pharmaceutical Business Overview
7.13.3 Guangzhou Bositao Controlled Release Pharmaceutical Chemical CDMO Major Product Offerings
7.13.4 Guangzhou Bositao Controlled Release Pharmaceutical Chemical CDMO Revenue in Global Market (2018-2023)
7.13.5 Guangzhou Bositao Controlled Release Pharmaceutical Key News & Latest Developments
7.14 Charles River
7.14.1 Charles River Company Summary
7.14.2 Charles River Business Overview
7.14.3 Charles River Chemical CDMO Major Product Offerings
7.14.4 Charles River Chemical CDMO Revenue in Global Market (2018-2023)
7.14.5 Charles River Key News & Latest Developments
7.15 Cambrex
7.15.1 Cambrex Company Summary
7.15.2 Cambrex Business Overview
7.15.3 Cambrex Chemical CDMO Major Product Offerings
7.15.4 Cambrex Chemical CDMO Revenue in Global Market (2018-2023)
7.15.5 Cambrex Key News & Latest Developments
7.16 Almac Group
7.16.1 Almac Group Company Summary
7.16.2 Almac Group Business Overview
7.16.3 Almac Group Chemical CDMO Major Product Offerings
7.16.4 Almac Group Chemical CDMO Revenue in Global Market (2018-2023)
7.16.5 Almac Group Key News & Latest Developments
7.17 Jubilant Pharmova
7.17.1 Jubilant Pharmova Company Summary
7.17.2 Jubilant Pharmova Business Overview
7.17.3 Jubilant Pharmova Chemical CDMO Major Product Offerings
7.17.4 Jubilant Pharmova Chemical CDMO Revenue in Global Market (2018-2023)
7.17.5 Jubilant Pharmova Key News & Latest Developments
7.18 Cambrex
7.18.1 Cambrex Company Summary
7.18.2 Cambrex Business Overview
7.18.3 Cambrex Chemical CDMO Major Product Offerings
7.18.4 Cambrex Chemical CDMO Revenue in Global Market (2018-2023)
7.18.5 Cambrex Key News & Latest Developments
7.19 Siegfried Holding AG
7.19.1 Siegfried Holding AG Company Summary
7.19.2 Siegfried Holding AG Business Overview
7.19.3 Siegfried Holding AG Chemical CDMO Major Product Offerings
7.19.4 Siegfried Holding AG Chemical CDMO Revenue in Global Market (2018-2023)
7.19.5 Siegfried Holding AG Key News & Latest Developments
7.20 Aenova Group
7.20.1 Aenova Group Company Summary
7.20.2 Aenova Group Business Overview
7.20.3 Aenova Group Chemical CDMO Major Product Offerings
7.20.4 Aenova Group Chemical CDMO Revenue in Global Market (2018-2023)
7.20.5 Aenova Group Key News & Latest Developments
7.21 Samsung BioLogics
7.21.1 Samsung BioLogics Company Summary
7.21.2 Samsung BioLogics Business Overview
7.21.3 Samsung BioLogics Chemical CDMO Major Product Offerings
7.21.4 Samsung BioLogics Chemical CDMO Revenue in Global Market (2018-2023)
7.21.5 Samsung BioLogics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer